Do you want to read an article? Please log in or register.
Cardiac Biomarkers in Patients with Asymptomatic Severe Aortic Stenosis: Analysis from the EARLY TAVR Trial
Heart, Artery and Coronary DiseasesTherapy and Intervention
Indications
Related content
Heart, Artery and Coronary DiseasesTherapy and Intervention
ACURATE neo2 valve versus commercially available transcatheter heart valves in patients with severe aortic stenosis (ACURATE IDE): a multicentre, randomised, controlled, non-inferiority trial
Lancet
Makkar RR, Ramana RK, Gnall E, Ramlawi B, Cheng W, Diamantouros P, Potluri S, Kleinman N, Gupta A, Chakravarty T, Samy S, Rassi A, Rajagopal V, Yakubov S, Sorajja P, Patel D, Garcia S, Yadav P, Thourani V, Wang J, Rinaldi M, Kapadia S, Waksman R, Webb J, Ren CB, Gregson J, Modolo R, Sathananthan J, Reardon MJ, ACURATE IDE study investigators
doi: 10.1016/S0140-6736(25)00319-8
Heart, Artery and Coronary DiseasesTherapy and Intervention
Prognostic Value of Myocardial CT-ECV in Severe Aortic Stenosis Requiring Aortic Valve Replacement: A Systematic Review and Meta-analysis
Eur Heart J Cardiovasc Imaging
Faggiano A, Gherbesi E, Carugo S, Brusamolino M, Cozac DA, Cozza E, Savo MT, Cannata F, Guglielmo M, La Mura L, Fazzari F, Carrabba N, Conte E, Mushtaq S, Baggiano A, Guaricci AI, Pedrinelli R, Indolfi C, Sinagra G, Perrone Filardi P, Pergola V, Pontone G
doi: 10.1093/ehjci/jeae324
Heart Failure
Percutaneous repair of moderate-to-severe or severe functional mitral regurgitation in patients with symptomatic heart failure: Baseline characteristics of patients in the RESHAPE-HF2 trial and comparison to COAPT and MITRA-FR trials
Eur J Heart Fail
Anker SD, Friede T, von Bardeleben RS, Butler J, Khan MS, Diek M, Heinrich J, Geyer M, Placzek M, Ferrari R, Abraham WT, Alfieri O, Auricchio A, Bayes-Genis A, Cleland JGF, Filippatos G, Gustafsson F, Haverkamp W, Kelm M, Kuck KH, Landmesser U, Maggioni AP, Metra M, Ninios V, Petrie MC, Rassaf T, Ruschitzka F, Schäfer U, Schulze PC, Spargias K, Vahanian A, Zamorano JL, Zeiher A, Karakas M, Koehler F, Lainscak M, Öner A, Mezilis N, Theofilogiannakos EK, Ninios I, Chrissoheris M, Kourkoveli P, Papadopoulos K, Smolka G, Wojakowski W, Reczuch K, Pinto FJ, Zmudka K, Kalarus Z, Adamo M, Santiago-Vacas E, Ruf TF, Gross M, Tongers J, Hasenfuß G, Schillinger W, Ponikowski P
doi: 10.1002/ejhf.3286
Heart, Artery and Coronary DiseasesTherapy and Intervention
Surgical vs Transcatheter Treatment in Patients With Coronary Artery Disease and Severe Aortic Stenosis
JACC Cardiovasc Interv
Amat-Santos IJ, García-Gómez M, Avanzas P, Jiménez-Diaz V, Alonso-Briales JH, de la Torre Hernández JM, Sanz-Sánchez J, Diarte-de Miguel JA, Sánchez-Recalde Á, Nombela-Franco L, Jiménez-Mazuecos J, Serra V, Nogales-Asensio JM, García-Blas S, Gómez-Menchero A, Del Valle R, Mayor Déniz C, Al Houssaini W, Veiga-Fernández G, Diez-Gil JL, Jimeno Sánchez J, López Menéndez J, Fernández-Cordón C, Gómez-Salvador I, Bustamante-Munguira J, Kedhi E, San Román JA
doi: 10.1016/j.jcin.2024.09.003
Heart, Artery and Coronary DiseasesTherapy and Intervention
Trends in Transcatheter Versus Surgical Aortic Valve Replacement Outcomes in Patients With Low-Surgical Risk: A Systematic Review and Meta-Analysis of Randomized Trials
J Am Heart Assoc
Kazemian S, Fallahtafti P, Sharifi M, Mohammadi NSH, Soleimani H, Moghadam AS, Karimi E, Sattar Y, Jenab Y, Mehrani M, Hajizeinali A, Iskander M, Sabet MF, Salehi N, Al-Azizi K, Hakim D, Alam M, Hosseini K
doi: 10.1161/JAHA.124.036179
Further Publications
Cardiac transthyretin amyloidosis treatment improves outcomes after aortic valve replacement for severe stenosis
Eur Heart J
Nitsche C, Dobner S, Rosenblum HR, Patel KP, Longhi S, Yilmaz A, Merlo M, Papathanasiou M, Griffin J, Oerlemans MIFJ, Gama F, Hamdan A, Kelion AD, Schuster A, Glaveckaité S, Akyol N, Porcari A, Schlender L, Capovilla T, Autherith M, Hauptmann L, Halavina K, Cavalcante JL, Fontana M, Scully PR, Moon JC, Mascherbauer J, Ristl R, Biagini E, Stortecky S, Maurer MS, Treibel TA, AS-Amyloidosis Consortium
doi: 10.1093/eurheartj/ehaf362
Heart Failure
Early integration of palliative care versus standard cardiac care for patients with heart failure (EPCHF): a multicentre, parallel, two-arm, open-label, randomised controlled trial
Lancet Healthy Longev
Balata M, Radbruch L, Hesse M, Westenfeld R, Neukirchen M, Pfister R, Batzler YN, Öztürk C, Kavsur R, Tiyerili V, Weltermann B, Pölsler R, Standl T, Nickenig G, Becher MU, Heart Failure Network Rhineland
doi: 10.1016/j.lanhl.2024.08.006
Heart, Artery and Coronary DiseasesTherapy and Intervention
5-Year Outcomes After Transcatheter or Surgical Aortic Valve Replacement in Low-Risk Patients With Aortic Stenosis
J Am Coll Cardiol
Forrest JK, Yakubov SJ, Deeb GM, Gada H, Mumtaz MA, Ramlawi B, Bajwa T, Crouch J, Merhi W, Wai Sang SL, Kleiman NS, Petrossian G, Robinson NB, Sorajja P, Iskander A, Berthoumieu P, Tchétché D, Feindel C, Horlick EM, Saito S, Oh JK, Jung Y, Reardon MJ, Low Risk Trial Investigators
doi: 10.1016/j.jacc.2025.03.004
Cardiac Arrest or Death
Effects of very early hyperoxemia on neurologic outcome after out-of-hospital cardiac arrest: A secondary analysis of the TTM-2 trial
Resuscitation
Sanfilippo F, Uryga A, Santonocito C, Jakobsen JC, Lilja G, Friberg H, Wendel-Garcia PD, Young PJ, Eastwood G, Chew MS, Unden J, Thomas M, Grejs AM, Wise MP, Lundin A, Hollenberg J, Hammond N, Saxena M, Martin A, Bánszky R, Taccone FS, Dankiewicz J, Nielsen N, Ebner F, BeloholaveK J, Hanggi M, Montagnani L, Patroniti N, Robba C, TTM-2 investigators
doi: 10.1016/j.resuscitation.2024.110460